Screener
National Health Investors NHI Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 38.6%-2.4pp | 36.9%-4.3pp | 37.9%-3.3pp | 41.4%+2.9pp | 41%+1.9pp | |
| Returns | ||||||
| Return on equity | 10.9%+0.4pp | 10.1%-0.5pp | 9.8%-0.7pp | 10.9%+0.7pp | 10.5%+0.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×+0.1× | 0.9×0.0× | 0.8×-0.1× | 0.7×-0.4× | 0.8×-0.4× | |
| Per Share | ||||||
| Book value per share | $32.40+2.5% | $31.20+0.4% | $32.34+4.4% | $31.10+11.3% | $31.60+10.6% | |
| Valuation | ||||||
| Market capitalization | $3.2B-14.4% | $3.92B+16.1% | $3.64B+15.6% | $3.77B+3.5% | $3.36B+14.4% | |
| Price / earnings | 19.2×-6.2× | 26.5×+2.6× | 25.6×+2.8× | 25.6×-3.1× | 23.5×+0.5× | |
| Price / sales | 7.4×-3.1× | 9.8×-0.1× | 9.7×+0.3× | 10.6×-0.5× | 9.6×+0.6× | |
| Price / book | 2×-0.5× | 2.6×+0.2× | 2.4×+0.1× | 2.5×-0.4× | 2.3×-0.1× | |
| Dividend yield | 5.5%+1.1pp | 4.4%-0.3pp | 4.7%-0.3pp | 4.4%+0.1pp | 4.8%-0.5pp |
FAQ
- Where do National Health Investors's ratios come from?
- Every ratio is computed from National Health Investors's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
